ArticleJournal of diabetes and metabolic disorders2015

Efficacy and tolerability of vildagliptin as first line treatment in patients with diabetes type 2 in an outpatient setting.

M P Yavropoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.